Ｃｌａｒｉｏｎ　１６人工内耳　　システム紹介と本邦における使用経験を中心として

河野 淳, 舩坂 宗太郎, 冨澤 文子, 力藤 朗夫, 椎田 宏, 博久 詠司, 佐藤 千穂, 鈴木 衛

doi:10.3950/jibiinkoka.101.5_578

Ｃｌａｒｉｏｎ　１６人工内耳　　システム紹介と本邦における使用経験を中心として

DOI PubMed 被引用文献1件参考文献6件

河野淳

東京医科大学耳耳咽喉科教室
舩坂宗太郎
冨澤文子

東京医科大学耳耳咽喉科教室
力藤朗夫

東京医科大学耳耳咽喉科教室
椎田宏

東京医科大学耳耳咽喉科教室
博久詠司

東京医科大学耳耳咽喉科教室
佐藤千穂

東京医科大学耳耳咽喉科教室
鈴木衛

東京医科大学耳耳咽喉科教室

書誌事項

タイトル別名

Clarion 16 Cochlear Implant(System Introduction and Use Experience in Japan).
System Introduction and Use Experience in Japan
システム紹介と本邦における使用経験を中心として

この論文をさがす

説明

The Clarion cochlear implant was developed in the USA and received FDA approval in August 1996. It consists of an implantable cochlear stimulator (ICS), speech processor with headpiece, and in addition, a clinician's programming system and portable cochlear implant tester. One of the features of the device is its stimulationcoding process for which two methods of continuous interleaved sampling (CIS) and compressed analogue (CA) are applicable. Regardless of which is used, stimulation can be provided over 8 channels. The device was used in 2 cases. Both patients were operated on in October 1996, and 16 electrodes in 8 pairs were mounted in the cochlea. Mapping, performed 3 weeks after the operation, showed good speech perception in both patients with only a cochlear implant in the "open-set " status. CIS was used as the stimulation coding method. CA has yet to be applied.